Skip to content

Clinical trials

Primary Myelofibrosis trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: Czechia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20141
20171
20181
20192
20202
20213
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
CTI BioPharma2
Celgene2
Kartos Therapeutics, Inc.2
Karyopharm Therapeutics Inc2
Sierra Oncology LLC - a GSK company2
AbbVie1
European Organisation for Research and Treatment of Cancer - EORTC1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis18
Myeloproliferative Disorders7
Anemia6
Bone Marrow Diseases4
Hematologic Diseases4
Polycythemia Vera4
Thrombocythemia, Essential4
Splenomegaly3
Thrombocytopenia3
Hemorrhagic Disorders2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.